Cargando…

Cost-Effectiveness of Atrial Fibrillation Screening Strategies: A Systematic Review

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF is associated with an increased risk of stroke. We aimed to review systematically the cost-effectiveness of screening strategies for patients with AF. METHODS: To find related research and articles, articles published in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abolghasem Gorji, Hassan, Khosravi, Majid, Mahmoodi, Razieh, Hasoumi, Mojtaba, Souresrafil, Aghdas, Alipour, Vahid, Rezapour, Aziz, Hajahmadi, Marjan, Azari, Samad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404313/ https://www.ncbi.nlm.nih.gov/pubmed/37551181 http://dx.doi.org/10.18502/ijph.v52i4.12435

Ejemplares similares

The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran
por: Rezapour, Aziz, et al.
Publicado: (2021)

Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in Low and Middle-Income Countries: A Systematic Review
por: Souresrafil, Aghdas, et al.
Publicado: (2022)

Economic evaluation of single-photon emission-computed tomography versus stress echocardiography in stable chest pain patients
por: Javan-Noughabi, Javad, et al.
Publicado: (2022)

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
por: Rezapour, Aziz, et al.
Publicado: (2023)

Economic evaluation of programs against COVID-19: A systematic review
por: Rezapour, Aziz, et al.
Publicado: (2021)

Medical therapy versus percutaneous coronary intervention in ischemic heart disease: A cost-effectiveness analysis
por: Rezapour, Aziz, et al.
Publicado: (2020)

The impact of disease characteristics on multiple sclerosis patients’ quality of life
por: Rezapour, Aziz, et al.
Publicado: (2017)

Medical costs of osteoporosis in the Iranian elderly patients
por: Alipour, Vahid, et al.
Publicado: (2020)

Study of health resource and health outcomes: Organization of economic corporation and development panel data analysis
por: Hosseini Jebeli, Seyede Sedighe, et al.
Publicado: (2019)

The burden of nonrheumatic valvular heart diseases in Iran between 1990 and 2017: Results from the global burden of disease study 2017
por: Arabloo, Jalal, et al.
Publicado: (2022)

Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
por: Behzadifar, Masoud, et al.
Publicado: (2018)

The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework
por: Behzadifar, Masoud, et al.
Publicado: (2019)

Prevalence of hepatitis C virus among street children in Iran
por: Behzadifar, Masoud, et al.
Publicado: (2018)

Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia
por: Behzadifar, Masoud, et al.
Publicado: (2019)

Cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for the adjuvant treatment of early breast cancer: A systematic review
por: Eisavi, Mahmoud, et al.
Publicado: (2020)

Comparing the effectiveness of revascularization interventions with medical therapy in patients with ischemic cardiomyopathy: A systematic review and meta-analysis
por: Bagheri Faradonbeh, Saeed, et al.
Publicado: (2018)

The role of insurance providers in supporting treatment and management of hepatitis C patients
por: Behzadifar, Masoud, et al.
Publicado: (2019)

Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System: A Systematic Review
por: Azari, Samad, et al.
Publicado: (2023)

Economic, Cultural, and Political Requirements for Medical Tourism Development in Iran: Insights from a Fuzzy Analytical Hierarchy Process Method
por: Sarabi Asiabar, Ali, et al.
Publicado: (2021)

Hospital Expenditure at the End-of-Life: A Time-to-Death Approach
por: Alipour, Vahid, et al.
Publicado: (2020)

The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
por: Behzadifar, Masoud, et al.
Publicado: (2018)

Cost of Illness of Tuberculosis in Tehran in the Year 2011
por: Hasoumi, Mojtaba, et al.
Publicado: (2014)

Cost-Effectiveness of Multifactorial Interventions in Preventing Falls among Elderly Population: A Systematic Review
por: Alipour, Vahid, et al.
Publicado: (2021)

Effects of private and public health expenditure on health outcomes among countries with different health care systems: 2000 and 2014
por: Raeesi, Pouran, et al.
Publicado: (2018)

Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis
por: Behzadifar, Masoud, et al.
Publicado: (2019)

Effectiveness of revascularization interventions compared with medical therapy in patients with ischemic cardiomyopathy: A systematic review protocol
por: Rezapour, Aziz, et al.
Publicado: (2018)

Elderly's food security and its associated socioeconomic determinants in Tehran: A cross‐sectional study
por: Alipour, Vahid, et al.
Publicado: (2021)

A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran
por: Yusefzadeh, Hassan, et al.
Publicado: (2015)

Cost of dabigatran for atrial fibrillation
por: Gage, Brian F
Publicado: (2011)

The Impact of Inflation and Its Uncertainty on Pharmaceutical Prices: Evidence from Iran
por: Soleimani Movahed, Maryam, et al.
Publicado: (2021)

Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
por: Ravangard, Ramin, et al.
Publicado: (2023)

Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: A systematic review
por: Tashakori-Miyanroudi, Mahsa, et al.
Publicado: (2021)

Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
por: Ebadi Fard Azar, Amir Ali, et al.
Publicado: (2017)

Ageing and inpatient hospital expenditures: A study of steepening
por: Alipour, Vahid, et al.
Publicado: (2018)

Atrial fibrillation: the cost of illness in Sweden
por: Ericson, Lisa, et al.
Publicado: (2010)

Burden of Hypertensive Heart Disease in Iran during 1990–2017: Findings from the Global Burden of Disease study 2017
por: Omidi, Negar, et al.
Publicado: (2021)

Cost of Tuberculosis Treatment: Evidence from Iran’s Health System
por: Bay, Vahid, et al.
Publicado: (2017)

Assessing Iran’s health system according to the COVID-19 strategic preparedness and response plan of the World Health Organization: health policy and historical implications
por: GHANBARI, MAHBOUBEH KHATON, et al.
Publicado: (2021)

Sleep Quality in Iranian Hemodialysis Patients: A Systematic Review and Meta-analysis
por: Mirghaed, Masood Taheri, et al.
Publicado: (2019)

Cost-Effectiveness of Sacubitril/Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction: A Systematic Review
por: Rezapour, Aziz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t6il7dddgla79sdafb13rt1u05